A Phase 1a/b Study of IK-175 as a Single Agent and in Combination With Nivolumab in Patients With Locally Advanced or Metastatic Solid Tumors and Urothelial Carcinoma
Ikena Oncology
Ikena Oncology
Rainier Therapeutics
Rainier Therapeutics
Endo Pharmaceuticals
UroGen Pharma Ltd.
UroGen Pharma Ltd.
UroGen Pharma Ltd.
Medical Enterprises Europe B.V.
Merck Sharp & Dohme LLC
Medical Enterprises Europe B.V.